Tag: exact sciencesSort
(STRL, EXAS, DXPE, CRWE) DoubleInStocks.com Stock Market Updates
EXACT Sciences Corporation Accomplished Record New Price of 52 Weeks - NASDAQ:EXAS
EXACT Sciences Corporation (NASDAQ:EXAS) is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. EXACT Sciences Corporation achieved its new 52 week high price of $9.59 where it was opened at $9.40 down -0.10 points or -1.05% by closing at $9.39.
OPTR, ESLR, PWRM, EXAS, EGI - Stock Report, News, and Must Watch Video!! From PennyOmega.com
Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) announced the presentation of information from insurance claims and survey databases highlighting the unmet need for targeted therapies to treat subpopulations at high risk of recurrence of Clostridium difficile infection (CDI). The research also presented the substantial mortality and frequent complications associated with CDI.
EXAS, GRHU, SPU, AVOT, CTGX - Stock Review From DoubleInStocks.com!
GRHU, PWRM, ZIXI, ARIA, EXAS, - GreenHouse Holdings, Power3 Medical Products, Zix, ARIAD Pharmaceuticals and Exact Sciences
GreenHouse Holdings, Inc. (OTCQB:GRHU) previously announced the signing of multiple contract awards for its Life Protection (LPI) Governmental Services Division, totaling $6 million. The recently acquired LPI subsidiary provides innovative training, support, design and construction of facilities and services to meet the needs of the U. S. Government, military, and law enforcement agencies.
MSPD, GRHU, EXAS, LLNW - Mindspeed, GreenHouse Holdings, Exact Sciences, Limelight
BFLY, GRHU, EXAS, NTRS - Bluefly, GreenHouse Holdings, Exact Sciences, Northern Trust
When BioTechnology Businesses Go All The Way - DrStockPick.com - PROT, EXAS
DrStockPick Has The Latest News And Updates From EXAR, EXAC, PROT and EXAS!
PennyOtcStock Market Report on PROT.OB, EPM, EVOL, EXAS
Proteonomix, Inc., (OTCBB:PROT.OB)a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced recently that Mr. Michael Cohen, Chairman and CEO, is scheduling a multi-city European road trip to create additional awareness of the Proteonomix, Inc. investment opportunity to institutional investors.